Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (PBH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pbh · stock forecast · 17 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$66.00
Consensus
$66.00
+38.3% upside
Low
$66.00
Median: $66 · Last Close: $47.72
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $46.53 | ↓ 2.49% |
1-day model range: $46.21–$46.85. Peak: $46.85 (-2.49%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $46 | -2.9% |
| 2028 | $46 | -4.6% |
| 2029 | $45 | -5.6% |
| 2030 | $45 | -6.2% |
| 2031 | — | -6.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PBH · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-14 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2026-05-07 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-02 | Jefferies | Maintains | Hold→Hold |
| 2025-11-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-10-27 | Jefferies | Maintains | Hold→Hold |
| 2025-10-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-08-08 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-03-21 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-02-13 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Prestige Consumer Healthcare Inc. (PBH) stock. Of the recent 72 rating actions, 12 were upgrades and 6 were downgrades. 17 analysts currently cover PBH.
Analyst Recommendation Trends
PBH analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.2B
↓ 16.1% YoY
Revenue Next Year
$1.3B
↑ 6.9% YoY
EPS This Year
$4.54
EPS Next Year
$4.90
↑ 8.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast PBH EPS of $4.54 for the current fiscal year, based on estimates from 3 analysts. The PBH revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PBH stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PBH price target is $66.00 (+38.3% upside), with an analyst consensus of Buy.
The PBH short-term stock prediction for tomorrow is $46.53 (-2.49%). The PBH stock price prediction for 2027 estimates an average of $46. The PBH stock prediction for 2030 projects a range of $42–$47.
Prestige Consumer Healthcare Inc. trades on NYSE under the ticker PBH. The PBH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 65% of covering analysts.
Frequently asked questions
PBH forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month PBH price target is $66.00, with a high forecast of $66.00 and a low of $66.00. The median price target is shown in the chart above when available. This implies +38.3% potential upside from the current price of $47.72.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.